NCT05076669

Brief Summary

In this context, FSK would like to implement a clinical study to assess the added value on the health-related QoL from the enhanced follow-up of ostomy patients by a HHN including stomal therapists. The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites. The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

10 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 13, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

October 13, 2021

Status Verified

September 1, 2021

Enrollment Period

1.8 years

First QC Date

September 21, 2021

Last Update Submit

September 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy

    score from the Stoma-QOL specific questionnaire (min: 0- max: 100), analysis of the mean

    3 months

Secondary Outcomes (5)

  • Satisfaction of patient

    3 and 6 months

  • Quality of life

    1, 2, 3 and 6 months

  • Quality of life

    1, 2, 3 and 6 months

  • Cost

    3 and 6 months

  • Morbidity

    3 and 6 months

Study Arms (2)

Control

ACTIVE COMPARATOR

The control group will receive the routine care prescribed by the sites and will be provided with ostomy equipment by FSK.

Other: standard of care

interventional group

EXPERIMENTAL

The interventional group will benefit from delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites.

Other: stoma follow-up

Interventions

delivery and enhanced follow-up by the FSK HHN provided, in particular, by stomal therapy nurse consultants and patient-relation experts during in-person or remote appointments in addition to the routine care delivered and prescribed by the sites

interventional group

routine management of stoma

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥ 18 years
  • Patients with a stoma placed less than 10 days ago
  • Patients who had a stoma during their current hospitalisation
  • Patients informed verbally and in writing via the information sheet and who signed the informed consent form.

You may not qualify if:

  • Patients in palliative care
  • Patients participating in another clinical study interested in the management of ostomy patients
  • Patients not enrolled in a social security system or with the CMU (Couverture maladie universelle \[Universal Health Coverage\])
  • Patients under judicial protection or under guardianship
  • Patients deprived of freedom (in prison and psychiatric patients being treated without consent)
  • Patients with difficulties understanding or reading French

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Hopital Bicètre

Le Kremlin-Bicêtre, 93043, France

Location

Hopital Lyon-Sud

Lyon, France

Location

Hopital SAint Louis

Paris, 75009, France

Location

Hopital Saint-Louis

Paris, 75009, France

Location

Hopital Saint-Antoine

Paris, 75012, France

Location

Hopital de la Pitié-Salpétrière

Paris, 75013, France

Location

Hopital HEGP

Paris, 75015, France

Location

ESPIC FOCH - Digestige Unit

Suresnes, France

Location

ESPIC Foch - Urology Unit

Suresnes, France

Location

CHU Toulouse

Toulouse, France

Location

Related Publications (5)

  • Becker A, Schulten-Oberborsch G, Beck U, Vestweber KH. Stoma care nurses: good value for money? World J Surg. 1999 Jul;23(7):638-42; discussion 642-3. doi: 10.1007/pl00012361.

    PMID: 10390579BACKGROUND
  • Persson E, Berndtsson I, Carlsson E, Hallen AM, Lindholm E. Stoma-related complications and stoma size - a 2-year follow up. Colorectal Dis. 2010 Oct;12(10):971-6. doi: 10.1111/j.1463-1318.2009.01941.x.

  • Neil N, Inglese G, Manson A, Townshend A. A Cost-Utility Model of Care for Peristomal Skin Complications. J Wound Ostomy Continence Nurs. 2016 Jan-Feb;43(1):62-8. doi: 10.1097/WON.0000000000000194.

  • Marquis P, Marrel A, Jambon B. Quality of life in patients with stomas: the Montreux Study. Ostomy Wound Manage. 2003 Feb;49(2):48-55.

  • Danielsen AK, Rosenberg J. Health related quality of life may increase when patients with a stoma attend patient education--a case-control study. PLoS One. 2014 Mar 7;9(3):e90354. doi: 10.1371/journal.pone.0090354. eCollection 2014.

Related Links

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jeremie H Lefevre, MD, PhD

    Sorbonne University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Open-label, randomised, comparative, controlled, national and multi-centre study with minimal risks and constraints to routine care.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2021

First Posted

October 13, 2021

Study Start

October 1, 2021

Primary Completion

August 1, 2023

Study Completion

December 1, 2023

Last Updated

October 13, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations